J&J In Talks to Buy Inverness Unit

Also: news on Newport News, Carter-Wallace and others

Johnson & Johnson (JNJ ) is in talks to buy Inverness Medical's (IMA ) diabetes care unit unit in a $1.3B stock deal; Inverness would split off its nutritional supplements, women's health, and clinical diagnostics units to form a new public company. (5/9)

To continue reading this article you must be a Bloomberg Professional Service Subscriber.